RaNA

RaNA Therapeutics buys out Shire’s mRNA platform

RaNA Therapeutics has acquired Shire’s mRNA therapy platform, originally developed by its MRT employees, who have also now joined RaNA as part of the deal.

Ben Adams Jan 4, 2017 7:30am